Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Theravance Biopharma (TBPH): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Neutral
7 analysts
Options Flow (P/C)
—
Avg Consensus PT
$15
-13.5%
Highest Price Target
$17
-0.3%
Lowest Price Target
$10
-41.3%
Short Interest
5.2%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | BTIG | Julian Harrison— | — | — | Suspends | Neutral |
| Jul 7, 2026 | HC Wainwright & Co. | Douglas Tsao— | -0.3% | $15 → $17 | Downgrade | Buy→Neutral |